Articles of interest – International Liver Cancer Association

Risk of hepatocellular carcinoma on alcoholic and non-alcoholic fatty liver disease

Journal of Hepatology, 27 May 2019

Genomic and transcriptomic profiling of combined hepatocellular and intrahepatic cholangiocarcinoma reveals distinct molecular subtypes

Cancer Cell, 23 May 2019

Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma

Journal of Hepatology, 21 May 2019

Sorafenib plus hepatic arterial infusion (HAIC) of oxaliplatin, fluorouracil, and leucovorin vs sorafenib alone for hepatocellular carcinoma with portal vein invasion (PVT): a randomized clinical trial

JAMA Oncology, 9 May 2019

Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer

Nature Medicine, 1 April 2019

Direct acting antiviral for hepatitis C after treatment of hepatocellular carcinoma

Gastroenterology, May 2019

Biomarkers associated with response to regorafenib in patients with hepatocellular carcinoma

Gastroenterology, May 2019

Somatic mutations increase hepatic clonal fitness and regeneration in chronic liver disease

Cell., 18 April 2019

Polyploidy spectrum: a new marker in HCC classification

Gut., 12 April 2019

p38γ is essential for cell cycle progression and liver tumorigenesis

Nature, 10 April 2019

12 3 4 5 6 7 8 10

page 1 of 11

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search